BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LAB LAB Testing

BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a strategic partnership with Camtech Health, a ...

February 22, 2024 | News

Thermo Fisher Scientific Expands GMP Labs with Biosafety and Mycoplasma Testing

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, is adding mycoplasma and additional biosafety tes...

February 13, 2024 | News

Azenta Introduces BioArc™ Ultra: Eco-Friendly Ultracold Sample Management

Azenta, Inc. announced the launch of the BioArc™ Ultra (the “Ultra”), a breakthrough, automated solution for high-density, eco-frie...

February 13, 2024 | News

BioAro and MyCare Revolutionize Genetic Testing, Advancing Detection of Serious Diseases

BioAro Inc., a leading international biotechnology company, has partnered with Assured Diagnostics Inc. to make their cutting-edge Whole Genome Sequencing ...

February 12, 2024 | News

SOPHiA GENETICS Expands Program with AstraZeneca Spain to Enhance Access to HRD Testing Across Spain

Originally launched in 2022, the collaboration between SOPHiA GENETICS and AstraZeneca Spain established HRD testing in five labs across the countr...

February 08, 2024 | News

SMC Laboratories Unveils STAM™-HCC/IO+ Mouse for Advancing Liver Cancer Drug Development in Immuno-Oncology

The company specializes in liver-related services and has evaluated test substances in over 15 MOA categories as well as over 270 target molecules us...

February 07, 2024 | News

QIAGEN Revolutionizes Diagnostic Testing with HSA Approval of QIAstat-Dx Meningitis/Encephalitis Panel

QIAGEN, a global leader in molecular diagnostics, proudly announces the approval of its QIAstat-Dx Meningitis/Encephalitis Panel by the Health Sciences Aut...

February 06, 2024 | News

QIAGEN Launches New Syndromic Tests in India for Rapid Disease Diagnosis

QIAGEN launches QIAstat-Dx Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, joining the Respiratory SARS-CoV-2 Panel QIAstat-Dx s...

February 06, 2024 | News

DELFi Diagnostics Launches Fragmentome-Based Cancer Treatment Monitoring Assay

DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced availability of the comp...

February 04, 2024 | News

QIAGEN Digital Insights Introduces Rapid NGS Analysis for Somatic Cancer

New software accelerator significantly reduces time and cost of NGS secondary analysis for somatic cancer, analyzing a 275-gene comprehensive cancer pane...

February 02, 2024 | News

LabCorp Launches New Test for Severe Preeclampsia Risk in Pregnant Women

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the launch and availability of a new, FDA-cle...

February 01, 2024 | News

Charles River Introduces First Rapid Animal-Free Bacterial Endotoxin Test

Building upon its flagship Endosafe® cartridge technology, Charles River Laboratories International, Inc. (NYSE: CRL) has advanced this innovation...

January 30, 2024 | News

Parse Biosciences Acquires Biomage

-Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has acquired data analysis software ...

January 17, 2024 | News

Guardant Health, Hikma Partner for Cancer Testing in the Middle East and North Africa

The partnership expands Guardant Health's global presence and includes products across the cancer care continuum. The tests offered include Shield™ f...

January 09, 2024 | News

Stay Connected